Home Infusion Therapy Market Likely to Surpass USD 60.1 Billion by 2035

• 1. Research Methodology and Assumptions
  • 1.1. Definitions
  • 1.2. Research Design and Approach
  • 1.3. Data Collection Methods
  • 1.4. Base Estimates and Calculations
  • 1.5. Forecasting Models
    • 1.5.1. Key Forecast Factors & Impact Analysis
  • 1.6. Secondary Research
    • 1.6.1. Open Sources
    • 1.6.2. Paid Databases
    • 1.6.3. Associations
  • 1.7. Primary Research
    • 1.7.1. Primary Sources
    • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
• 2. Executive Summary
  • 2.1. Global Home Infusion Therapy Market Outlook
    • 2.1.1. Home Infusion Therapy Market Size (Value - US$ Bn), and Forecasts, 2021-2035
    • 2.1.2. Compounded Annual Growth Rate Analysis
    • 2.1.3. Growth Opportunity Analysis
    • 2.1.4. Segmental Share Analysis
    • 2.1.5. Geographical Share Analysis
  • 2.2. Market Analysis and Facts
  • 2.3. Supply-Demand Analysis
  • 2.4. Competitive Benchmarking
  • 2.5. Go-to- Market Strategy
    • 2.5.1. Customer/ End-use Industry Assessment
    • 2.5.2. Growth Opportunity Data, 2026-2035
      • 2.5.2.1. Regional Data
      • 2.5.2.2. Country Data
      • 2.5.2.3. Segmental Data
    • 2.5.3. Identification of Potential Market Spaces
    • 2.5.4. GAP Analysis
    • 2.5.5. Potential Attractive Price Points
    • 2.5.6. Prevailing Market Risks & Challenges
    • 2.5.7. Preferred Sales & Marketing Strategies
    • 2.5.8. Key Recommendations and Analysis
    • 2.5.9. A Way Forward
• 3. Industry Data and Premium Insights
  • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
    • 3.1.1. Healthcare & Pharmaceutical Ecosystem Analysis
    • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
    • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
  • 3.2. Supplier Customer Data
  • 3.3. Technology Roadmap and Developments
• 4. Market Overview
  • 4.1. Market Dynamics
    • 4.1.1. Drivers
      • 4.1.1.1. Rising prevalence of chronic diseases requiring long-term infusion therapies
      • 4.1.1.2. Increasing shift from hospital-based care to home healthcare services
      • 4.1.1.3. Advancements in portable infusion pumps and remote patient monitoring technologies
    • 4.1.2. Restraints
      • 4.1.2.1. Risk of infusion-related complications and patient safety concerns in home settings
      • 4.1.2.2. Limited reimbursement coverage and regulatory complexities across regions
  • 4.2. Key Trend Analysis
  • 4.3. Regulatory Framework
    • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
    • 4.3.2. Tariffs and Standards
    • 4.3.3. Impact Analysis of Regulations on the Market
  • 4.4. Value Chain Analysis/ Ecosystem Analysis
  • 4.5. Porter’s Five Forces Analysis
  • 4.6. PESTEL Analysis
  • 4.7. Global Home Infusion Therapy Market Demand
    • 4.7.1. Historical Market Size – in Value (US$ Bn), 2020-2024
    • 4.7.2. Current and Future Market Size – in Value (US$ Bn), 2026–2035
      • 4.7.2.1. Y-o-Y Growth Trends
      • 4.7.2.2. Absolute $ Opportunity Assessment
• 5. Competition Landscape
  • 5.1. Competition structure
    • 5.1.1. Fragmented v/s consolidated
  • 5.2. Company Share Analysis, 2025
    • 5.2.1. Global Company Market Share
    • 5.2.2. By Region
      • 5.2.2.1. North America
      • 5.2.2.2. Europe
      • 5.2.2.3. Asia Pacific
      • 5.2.2.4. Middle East
      • 5.2.2.5. Africa
      • 5.2.2.6. South America
  • 5.3. Product Comparison Matrix
    • 5.3.1. Specifications
    • 5.3.2. Market Positioning
    • 5.3.3. Pricing
• 6. Global Home Infusion Therapy Market Analysis, by Product Type
  • 6.1. Key Segment Analysis
  • 6.2. Home Infusion Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Product Type, 2021-2035
    • 6.2.1. Infusion Pumps
      • 6.2.1.1. Ambulatory Infusion Pumps
      • 6.2.1.2. Implantable Infusion Pumps
      • 6.2.1.3. Syringe Infusion Pumps
      • 6.2.1.4. Enteral Infusion Pumps
      • 6.2.1.5. Insulin Infusion Pumps
      • 6.2.1.6. Others
    • 6.2.2. Intravenous Sets & Needles
      • 6.2.2.1. IV Catheters
      • 6.2.2.2. Needleless Connectors
      • 6.2.2.3. IV Administration Sets
      • 6.2.2.4. Others
    • 6.2.3. Supplies & Accessories
      • 6.2.3.1. Tubing & Extension Sets
      • 6.2.3.2. Filters
      • 6.2.3.3. Dressings & Tape
      • 6.2.3.4. Caps & Clamps
      • 6.2.3.5. Others        
• 7. Global Home Infusion Therapy Market Analysis, by Therapy Type
  • 7.1. Key Segment Analysis
  • 7.2. Home Infusion Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Therapy Type, 2021-2035
    • 7.2.1. Anti-Infective Therapy
      • 7.2.1.1. Antibiotic Infusion
      • 7.2.1.2. Antifungal Infusion
      • 7.2.1.3. Antiviral Infusion
    • 7.2.2. Hydration Therapy
    • 7.2.3. Chemotherapy
    • 7.2.4. Parenteral Nutrition
    • 7.2.5. Enteral Nutrition
    • 7.2.6. Pain Management Therapy
    • 7.2.7. Immunotherapy Therapy
    • 7.2.8. Specialty Infusion Therapy
• 8. Global Home Infusion Therapy Market Analysis, by Medication Type
  • 8.1. Key Segment Analysis
  • 8.2. Home Infusion Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Medication Type, 2021-2035
    • 8.2.1. Antibiotics
    • 8.2.2. Biologics & Biosimilars
    • 8.2.3. Antifungals
    • 8.2.4. Antivirals
    • 8.2.5. Specialty Pharmaceuticals
    • 8.2.6. Oncology Drugs
    • 8.2.7. Blood Clotting Factors
    • 8.2.8. Parenteral Nutrition Formulations
    • 8.2.9. Analgesics & Anesthetics
• 9. Global Home Infusion Therapy Market Analysis, by Patient Type
  • 9.1. Key Segment Analysis
  • 9.2. Home Infusion Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Patient Type, 2021-2035
    • 9.2.1. Pediatric Patients
    • 9.2.2. Adult Patients
    • 9.2.3. Geriatric Patients
• 10. Global Home Infusion Therapy Market Analysis, by Mode of Administration
  • 10.1. Key Segment Analysis
  • 10.2. Home Infusion Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Mode of Administration, 2021-2035
    • 10.2.1. Intravenous (IV)
    • 10.2.2. Subcutaneous
    • 10.2.3. Intramuscular
    • 10.2.4. Epidural
    • 10.2.5. Intrathecal
• 11. Global Home Infusion Therapy Market Analysis, by End-users
  • 11.1. Key Segment Analysis
  • 11.2. Home Infusion Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by End-users, 2021-2035
    • 11.2.1. Home Healthcare Providers
    • 11.2.2. Specialty Pharmacies
    • 11.2.3. Hospital Outpatient
    • 11.2.4. Long-Term Care Facilities
    • 11.2.5. Oncology & Cancer Care Centers
    • 11.2.6. Ambulatory Care Centers
    • 11.2.7. Rehabilitation Centers
    • 11.2.8. Others
• 12. Global Home Infusion Therapy Market Analysis, by Region
  • 12.1. Key Findings
  • 12.2. Home Infusion Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
    • 12.2.1. North America
    • 12.2.2. Europe
    • 12.2.3. Asia Pacific
    • 12.2.4. Middle East
    • 12.2.5. Africa
    • 12.2.6. South America
• 13. North America Home Infusion Therapy Market Analysis
  • 13.1. Key Segment Analysis
  • 13.2. Regional Snapshot
  • 13.3. North America Home Infusion Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
    • 13.3.1. Product Type
    • 13.3.2. Therapy Type
    • 13.3.3. Medication Type
    • 13.3.4. Patient Type
    • 13.3.5. Mode of Administration
    • 13.3.6. End-users
    • 13.3.7. Country
      • 13.3.7.1. USA
      • 13.3.7.2. Canada
      • 13.3.7.3. Mexico
  • 13.4. USA Home Infusion Therapy Market
    • 13.4.1. Country Segmental Analysis
    • 13.4.2. Product Type
    • 13.4.3. Therapy Type
    • 13.4.4. Medication Type
    • 13.4.5. Patient Type
    • 13.4.6. Mode of Administration
    • 13.4.7. End-users
  • 13.5. Canada Home Infusion Therapy Market
    • 13.5.1. Country Segmental Analysis
    • 13.5.2. Product Type
    • 13.5.3. Therapy Type
    • 13.5.4. Medication Type
    • 13.5.5. Patient Type
    • 13.5.6. Mode of Administration
    • 13.5.7. End-users
  • 13.6. Mexico Home Infusion Therapy Market
    • 13.6.1. Country Segmental Analysis
    • 13.6.2. Product Type
    • 13.6.3. Therapy Type
    • 13.6.4. Medication Type
    • 13.6.5. Patient Type
    • 13.6.6. Mode of Administration
    • 13.6.7. End-users
• 14. Europe Home Infusion Therapy Market Analysis
  • 14.1. Key Segment Analysis
  • 14.2. Regional Snapshot
  • 14.3. Europe Home Infusion Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
    • 14.3.1. Product Type
    • 14.3.2. Therapy Type
    • 14.3.3. Medication Type
    • 14.3.4. Patient Type
    • 14.3.5. Mode of Administration
    • 14.3.6. End-users
    • 14.3.7. Country
      • 14.3.7.1. Germany
      • 14.3.7.2. United Kingdom
      • 14.3.7.3. France
      • 14.3.7.4. Italy
      • 14.3.7.5. Spain
      • 14.3.7.6. Netherlands
      • 14.3.7.7. Nordic Countries
      • 14.3.7.8. Poland
      • 14.3.7.9. Russia & CIS
      • 14.3.7.10. Rest of Europe
  • 14.4. Germany Home Infusion Therapy Market
    • 14.4.1. Country Segmental Analysis
    • 14.4.2. Product Type
    • 14.4.3. Therapy Type
    • 14.4.4. Medication Type
    • 14.4.5. Patient Type
    • 14.4.6. Mode of Administration
    • 14.4.7. End-users
  • 14.5. United Kingdom Home Infusion Therapy Market
    • 14.5.1. Country Segmental Analysis
    • 14.5.2. Product Type
    • 14.5.3. Therapy Type
    • 14.5.4. Medication Type
    • 14.5.5. Patient Type
    • 14.5.6. Mode of Administration
    • 14.5.7. End-users
  • 14.6. France Home Infusion Therapy Market
    • 14.6.1. Country Segmental Analysis
    • 14.6.2. Product Type
    • 14.6.3. Therapy Type
    • 14.6.4. Medication Type
    • 14.6.5. Patient Type
    • 14.6.6. Mode of Administration
    • 14.6.7. End-users
  • 14.7. Italy Home Infusion Therapy Market
    • 14.7.1. Country Segmental Analysis
    • 14.7.2. Product Type
    • 14.7.3. Therapy Type
    • 14.7.4. Medication Type
    • 14.7.5. Patient Type
    • 14.7.6. Mode of Administration
    • 14.7.7. End-users
  • 14.8. Spain Home Infusion Therapy Market
    • 14.8.1. Country Segmental Analysis
    • 14.8.2. Product Type
    • 14.8.3. Therapy Type
    • 14.8.4. Medication Type
    • 14.8.5. Patient Type
    • 14.8.6. Mode of Administration
    • 14.8.7. End-users
  • 14.9. Netherlands Home Infusion Therapy Market
    • 14.9.1. Country Segmental Analysis
    • 14.9.2. Product Type
    • 14.9.3. Therapy Type
    • 14.9.4. Medication Type
    • 14.9.5. Patient Type
    • 14.9.6. Mode of Administration
    • 14.9.7. End-users
  • 14.10. Nordic Countries Home Infusion Therapy Market
    • 14.10.1. Country Segmental Analysis
    • 14.10.2. Product Type
    • 14.10.3. Therapy Type
    • 14.10.4. Medication Type
    • 14.10.5. Patient Type
    • 14.10.6. Mode of Administration
    • 14.10.7. End-users
  • 14.11. Poland Home Infusion Therapy Market
    • 14.11.1. Country Segmental Analysis
    • 14.11.2. Product Type
    • 14.11.3. Therapy Type
    • 14.11.4. Medication Type
    • 14.11.5. Patient Type
    • 14.11.6. Mode of Administration
    • 14.11.7. End-users
  • 14.12. Russia & CIS Home Infusion Therapy Market
    • 14.12.1. Country Segmental Analysis
    • 14.12.2. Product Type
    • 14.12.3. Therapy Type
    • 14.12.4. Medication Type
    • 14.12.5. Patient Type
    • 14.12.6. Mode of Administration
    • 14.12.7. End-users
  • 14.13. Rest of Europe Home Infusion Therapy Market
    • 14.13.1. Country Segmental Analysis
    • 14.13.2. Product Type
    • 14.13.3. Therapy Type
    • 14.13.4. Medication Type
    • 14.13.5. Patient Type
    • 14.13.6. Mode of Administration
    • 14.13.7. End-users
• 15. Asia Pacific Home Infusion Therapy Market Analysis
  • 15.1. Key Segment Analysis
  • 15.2. Regional Snapshot
  • 15.3. Asia Pacific Home Infusion Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
    • 15.3.1. Product Type
    • 15.3.2. Therapy Type
    • 15.3.3. Medication Type
    • 15.3.4. Patient Type
    • 15.3.5. Mode of Administration
    • 15.3.6. End-users
    • 15.3.7. Country
      • 15.3.7.1. China
      • 15.3.7.2. India
      • 15.3.7.3. Japan
      • 15.3.7.4. South Korea
      • 15.3.7.5. Australia and New Zealand
      • 15.3.7.6. Indonesia
      • 15.3.7.7. Malaysia
      • 15.3.7.8. Thailand
      • 15.3.7.9. Vietnam
      • 15.3.7.10. Rest of Asia Pacific
  • 15.4. China Home Infusion Therapy Market
    • 15.4.1. Country Segmental Analysis
    • 15.4.2. Product Type
    • 15.4.3. Therapy Type
    • 15.4.4. Medication Type
    • 15.4.5. Patient Type
    • 15.4.6. Mode of Administration
    • 15.4.7. End-users
  • 15.5. India Home Infusion Therapy Market
    • 15.5.1. Country Segmental Analysis
    • 15.5.2. Product Type
    • 15.5.3. Therapy Type
    • 15.5.4. Medication Type
    • 15.5.5. Patient Type
    • 15.5.6. Mode of Administration
    • 15.5.7. End-users
  • 15.6. Japan Home Infusion Therapy Market
    • 15.6.1. Country Segmental Analysis
    • 15.6.2. Product Type
    • 15.6.3. Therapy Type
    • 15.6.4. Medication Type
    • 15.6.5. Patient Type
    • 15.6.6. Mode of Administration
    • 15.6.7. End-users
  • 15.7. South Korea Home Infusion Therapy Market
    • 15.7.1. Country Segmental Analysis
    • 15.7.2. Product Type
    • 15.7.3. Therapy Type
    • 15.7.4. Medication Type
    • 15.7.5. Patient Type
    • 15.7.6. Mode of Administration
    • 15.7.7. End-users
  • 15.8. Australia and New Zealand Home Infusion Therapy Market
    • 15.8.1. Country Segmental Analysis
    • 15.8.2. Product Type
    • 15.8.3. Therapy Type
    • 15.8.4. Medication Type
    • 15.8.5. Patient Type
    • 15.8.6. Mode of Administration
    • 15.8.7. End-users
  • 15.9. Indonesia Home Infusion Therapy Market
    • 15.9.1. Country Segmental Analysis
    • 15.9.2. Product Type
    • 15.9.3. Therapy Type
    • 15.9.4. Medication Type
    • 15.9.5. Patient Type
    • 15.9.6. Mode of Administration
    • 15.9.7. End-users
  • 15.10. Malaysia Home Infusion Therapy Market
    • 15.10.1. Country Segmental Analysis
    • 15.10.2. Product Type
    • 15.10.3. Therapy Type
    • 15.10.4. Medication Type
    • 15.10.5. Patient Type
    • 15.10.6. Mode of Administration
    • 15.10.7. End-users
  • 15.11. Thailand Home Infusion Therapy Market
    • 15.11.1. Country Segmental Analysis
    • 15.11.2. Product Type
    • 15.11.3. Therapy Type
    • 15.11.4. Medication Type
    • 15.11.5. Patient Type
    • 15.11.6. Mode of Administration
    • 15.11.7. End-users
  • 15.12. Vietnam Home Infusion Therapy Market
    • 15.12.1. Country Segmental Analysis
    • 15.12.2. Product Type
    • 15.12.3. Therapy Type
    • 15.12.4. Medication Type
    • 15.12.5. Patient Type
    • 15.12.6. Mode of Administration
    • 15.12.7. End-users
  • 15.13. Rest of Asia Pacific Home Infusion Therapy Market
    • 15.13.1. Country Segmental Analysis
    • 15.13.2. Product Type
    • 15.13.3. Therapy Type
    • 15.13.4. Medication Type
    • 15.13.5. Patient Type
    • 15.13.6. Mode of Administration
    • 15.13.7. End-users
• 16. Middle East Home Infusion Therapy Market Analysis
  • 16.1. Key Segment Analysis
  • 16.2. Regional Snapshot
  • 16.3. Middle East Home Infusion Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
    • 16.3.1. Product Type
    • 16.3.2. Therapy Type
    • 16.3.3. Medication Type
    • 16.3.4. Patient Type
    • 16.3.5. Mode of Administration
    • 16.3.6. End-users
    • 16.3.7. Country
      • 16.3.7.1. Turkey
      • 16.3.7.2. UAE
      • 16.3.7.3. Saudi Arabia
      • 16.3.7.4. Israel
      • 16.3.7.5. Rest of Middle East
  • 16.4. Turkey Home Infusion Therapy Market
    • 16.4.1. Country Segmental Analysis
    • 16.4.2. Product Type
    • 16.4.3. Therapy Type
    • 16.4.4. Medication Type
    • 16.4.5. Patient Type
    • 16.4.6. Mode of Administration
    • 16.4.7. End-users
  • 16.5. UAE Home Infusion Therapy Market
    • 16.5.1. Country Segmental Analysis
    • 16.5.2. Product Type
    • 16.5.3. Therapy Type
    • 16.5.4. Medication Type
    • 16.5.5. Patient Type
    • 16.5.6. Mode of Administration
    • 16.5.7. End-users
  • 16.6. Saudi Arabia Home Infusion Therapy Market
    • 16.6.1. Country Segmental Analysis
    • 16.6.2. Product Type
    • 16.6.3. Therapy Type
    • 16.6.4. Medication Type
    • 16.6.5. Patient Type
    • 16.6.6. Mode of Administration
    • 16.6.7. End-users
  • 16.7. Israel Home Infusion Therapy Market
    • 16.7.1. Country Segmental Analysis
    • 16.7.2. Product Type
    • 16.7.3. Therapy Type
    • 16.7.4. Medication Type
    • 16.7.5. Patient Type
    • 16.7.6. Mode of Administration
    • 16.7.7. End-users
  • 16.8. Rest of Middle East Home Infusion Therapy Market
    • 16.8.1. Country Segmental Analysis
    • 16.8.2. Product Type
    • 16.8.3. Therapy Type
    • 16.8.4. Medication Type
    • 16.8.5. Patient Type
    • 16.8.6. Mode of Administration
    • 16.8.7. End-users
• 17. Africa Home Infusion Therapy Market Analysis
  • 17.1. Key Segment Analysis
  • 17.2. Regional Snapshot
  • 17.3. Africa Home Infusion Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
    • 17.3.1. Product Type
    • 17.3.2. Therapy Type
    • 17.3.3. Medication Type
    • 17.3.4. Patient Type
    • 17.3.5. Mode of Administration
    • 17.3.6. End-users
    • 17.3.7. Country
      • 17.3.7.1. South Africa
      • 17.3.7.2. Egypt
      • 17.3.7.3. Nigeria
      • 17.3.7.4. Algeria
      • 17.3.7.5. Rest of Africa
  • 17.4. South Africa Home Infusion Therapy Market
    • 17.4.1. Country Segmental Analysis
    • 17.4.2. Product Type
    • 17.4.3. Therapy Type
    • 17.4.4. Medication Type
    • 17.4.5. Patient Type
    • 17.4.6. Mode of Administration
    • 17.4.7. End-users
  • 17.5. Egypt Home Infusion Therapy Market
    • 17.5.1. Country Segmental Analysis
    • 17.5.2. Product Type
    • 17.5.3. Therapy Type
    • 17.5.4. Medication Type
    • 17.5.5. Patient Type
    • 17.5.6. Mode of Administration
    • 17.5.7. End-users
  • 17.6. Nigeria Home Infusion Therapy Market
    • 17.6.1. Country Segmental Analysis
    • 17.6.2. Product Type
    • 17.6.3. Therapy Type
    • 17.6.4. Medication Type
    • 17.6.5. Patient Type
    • 17.6.6. Mode of Administration
    • 17.6.7. End-users
  • 17.7. Algeria Home Infusion Therapy Market
    • 17.7.1. Country Segmental Analysis
    • 17.7.2. Product Type
    • 17.7.3. Therapy Type
    • 17.7.4. Medication Type
    • 17.7.5. Patient Type
    • 17.7.6. Mode of Administration
    • 17.7.7. End-users
  • 17.8. Rest of Africa Home Infusion Therapy Market
    • 17.8.1. Country Segmental Analysis
    • 17.8.2. Product Type
    • 17.8.3. Therapy Type
    • 17.8.4. Medication Type
    • 17.8.5. Patient Type
    • 17.8.6. Mode of Administration
    • 17.8.7. End-users
• 18. South America Home Infusion Therapy Market Analysis
  • 18.1. Key Segment Analysis
  • 18.2. Regional Snapshot
  • 18.3. South America Home Infusion Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
    • 18.3.1. Product Type
    • 18.3.2. Therapy Type
    • 18.3.3. Medication Type
    • 18.3.4. Patient Type
    • 18.3.5. Mode of Administration
    • 18.3.6. End-users
    • 18.3.7. Country
      • 18.3.7.1. Brazil
      • 18.3.7.2. Argentina
      • 18.3.7.3. Rest of South America
  • 18.4. Brazil Home Infusion Therapy Market
    • 18.4.1. Country Segmental Analysis
    • 18.4.2. Product Type
    • 18.4.3. Therapy Type
    • 18.4.4. Medication Type
    • 18.4.5. Patient Type
    • 18.4.6. Mode of Administration
    • 18.4.7. End-users
  • 18.5. Argentina Home Infusion Therapy Market
    • 18.5.1. Country Segmental Analysis
    • 18.5.2. Product Type
    • 18.5.3. Therapy Type
    • 18.5.4. Medication Type
    • 18.5.5. Patient Type
    • 18.5.6. Mode of Administration
    • 18.5.7. End-users
  • 18.6. Rest of South America Home Infusion Therapy Market
    • 18.6.1. Country Segmental Analysis
    • 18.6.2. Product Type
    • 18.6.3. Therapy Type
    • 18.6.4. Medication Type
    • 18.6.5. Patient Type
    • 18.6.6. Mode of Administration
    • 18.6.7. End-users
• 19. Key Players/ Company Profile
  • 19.1. Amedisys Inc.
    • 19.1.1. Company Details/ Overview
    • 19.1.2. Company Financials
    • 19.1.3. Key Customers and Competitors
    • 19.1.4. Business/ Industry Portfolio
    • 19.1.5. Product Portfolio/ Specification Details
    • 19.1.6. Pricing Data
    • 19.1.7. Strategic Overview
    • 19.1.8. Recent Developments
  • 19.2. B. Braun Mesiungen AG
  • 19.3. Baxter International Inc.
  • 19.4. Becton, Dickinson and Company (BD)
  • 19.5. BioScrip Inc.
  • 19.6. Coram LLC
  • 19.7. Fresenius Kabi AG
  • 19.8. Grifols S.A.
  • 19.9. ICU Medical Inc.
  • 19.10. Octapharma AG
  • 19.11. Option Care Health
  • 19.12. PharMerica Corporation
  • 19.13. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography